Skip to main content
Premium Trial:

Request an Annual Quote

ARUP Joins PierianDx Partner Network

NEW YORK (GenomeWeb) – ARUP Laboratories has joined PierianDx's partner network, the firms said today. ARUP will use PierianDx's workflow management tools and next-generation sequencing knowledgebase for its NGS-based clinical tests.

PierianDx was spun off earlier this year from Washington University in St. Louis. Its first product was the Clinical Genomicist Workstation, software developed by Wash U researchers, and the company also provides a knowledgebase of clinical information from thousands of previous genomic tests that its customers can tap into.

ARUP President and CEO Edward Ashwood said in a statement that PierianDx’s software and database will enable the lab to "more effectively learn from past assays and provide even more personalized recommendations to physicians so they can better match their patients to the right therapies."

In addition, PierianDx will benefit from "insight provided by ARUP clinical interpretations, variants, and related de-identified patient information," PierianDx CEO Ted Briscoe said in a statement.

The Scan

Close Panel Vote on Califf Nomination

The New York Times reports there was a close committee vote to advance the nomination of Robert Califf to lead the US Food and Drug Administration to the full Senate.

Task Force Reports on Scientific Integrity

Nature News writes that that a new task force report recommends that the US establish a cross-agency scientific integrity council.

Across the Hall

Genetic testing, closed-circuit cameras, and more show how a traveler, without any contact, infected others at a New Zealand quarantine facility, CNN reports.

Science Paper Examines Influence of Chromatin Modifications on Obsessive-Compulsive Disorder

In Science this week: genes regulating chromatin modification may contribute to OCD risk.